Compare JELD & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JELD | SEER |
|---|---|---|
| Founded | 1960 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Forest Products | Medicinal Chemicals and Botanical Products |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.9M | 97.3M |
| IPO Year | 2016 | 2020 |
| Metric | JELD | SEER |
|---|---|---|
| Price | $1.14 | $1.90 |
| Analyst Decision | Hold | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $3.43 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 143.0K |
| Earning Date | 05-04-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 9.40 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,211,181,000.00 | $16,578,000.00 |
| Revenue This Year | N/A | $2.14 |
| Revenue Next Year | $2.31 | $25.90 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 16.99 |
| 52 Week Low | $0.93 | $1.65 |
| 52 Week High | $6.98 | $2.41 |
| Indicator | JELD | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 38.43 | 66.36 |
| Support Level | N/A | $1.90 |
| Resistance Level | $2.06 | $1.97 |
| Average True Range (ATR) | 0.11 | 0.05 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 54.55 | 89.62 |
JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential and non-residential buildings. The firm's operating segments are North America, and Europe. It generates a majority of its revenue from North America.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.